Skip to main content
. 2024 Feb 16;16(2):281. doi: 10.3390/pharmaceutics16020281

Table 1.

Radical scavenging activity and biological properties of the RIV-IND hybrids as well as other reference compounds for comparison.

Compound n R1 R2 Antioxidant Activity a
EC50 (µM)
AChE Inhib b
IC50 (µM)
BChE Inhib b
IC50 (µM)
SI c 42 Self-Aggreg. Inhib d (%)
5a1 0 H H >2000 (18 ± 2) × 10 29.9 ± 0.4 6.0 26.9
5a2 0 OH H 8.4 ± 0.2 206 ± 4 3.22 ± 0.02 64.0 25.0
5a3 0 H OH 14.5 ± 0.5 10.9 ± 0.1 10.4 ± 0.4 1.05 50.3
5b1 1 H H >2000 78.4± 0.8 8.3 ± 0.1 9.4 19.9
5b2 1 OH H 7.8 ± 0.5 80 ± 2 27.1 ± 0.1 3.0 29.4
5b3 1 H OH 20.2 ± 0.4 80.7 ± 0.4 5.7 ± 0.3 14.2 47.8
5c1 2 H H >2000 40 ± 2 14.5 ± 0.7 2.8 25.6
5c2 2 OH H 8.5 ± 0.6 58.6 ± 0.3 15.2 ± 0.4 3.8 49.9
5c3 2 H OH 20.7 ± 0.4 26.8 ± 0.3 14.9 ± 0.7 1.8 55.5
Deferiprone - - - 148 ± 3 - -
Trolox - - - 13.8 ± 0.2 - -
Rivastigmine e - - - - 32.1 0.39 82.3
Curcumin e - - - - - - - 65.7

a Radical scavenging activity (DPPH method), with mean values of three independent experiments; b mean values of two independent experiments ± SD, performed with eeAChE and eqBChE; c selectivity index = IC50 (AChE)/IC50 (BChE); d mean values of two independent measurements in duplicate (SEM < 10%) for inhibition of Aβ42 aggregation (Cinhibitor = 20 µM) (thioflavin T fluorescence method); e Ref. [24].